NN-9041

N/A

Report date: 2025/03/13 15:11:05

Base Information

Drug NameNN-9041
Drug Alias NameDNA immunotherapy (Novo Nordisk)Type 1 diabetes therapeutic (Novo Nordisk)NN-9041NN9041
ClassificationCell and gene therapy > Gene therapy > Plasmid
Mechanisms of ActionGene transference
TargetsUpdating
Therapy Area/IndicationsDiabetes Mellitus, Type 1
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesNovo Nordisk A/S
China Registration ClassN/A

Develop Information

Active CompaniesNovo Nordisk A/S
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 1
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A